About

Paras Healthcare Limited operates in Hospital within the Healthcare sector.

Face value: ₹1

Market cap

₹8,724 Cr

P/E

—

P/B

—

Dividend yield

0%

ROE

—

ROCE

—

Debt / equity

—

OPM

—

EPS (TTM)

—

Book value

—

52-week high

—

52-week low

—

₹806.3+9.6%1Y

Quick read

rule-based

Pros

+High promoter holding of 64% with no pledge

Cons

No red flags triggered.

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Max Healthcare Institute LimitedMAXHEALTHMAXHEALTH	₹90,342 Cr	₹93,821 Cr	₹9,146 Cr	₹2,455 Cr	26.8%	₹1,381 Cr	17.2%	13.8%	14.3%	-110
Manipal Health Enterprises LimitedMANIPALHOSMANIPALHOS	₹89,112 Cr	₹99,665 Cr	₹10,336 Cr	₹2,611 Cr	25.3%	₹917 Cr	8.9%	12.5%	12.8%	38
Fortis Healthcare LimitedFORTISFORTIS	₹58,286 Cr	₹61,159 Cr	₹9,910 Cr	₹2,198 Cr	22.8%	₹1,038 Cr	11.7%	13%	11.1%	-99
Global Health LimitedMEDANTAMEDANTA	₹38,426 Cr	₹39,616 Cr	₹5,053 Cr	₹1,118 Cr	20.8%	₹613 Cr	12.6%	16.9%	15.1%	-26
Narayana Hrudayalaya Ltd.NHNH	₹38,149 Cr	₹43,015 Cr	₹10,273 Cr	₹1,901 Cr	20.5%	₹859 Cr	10.2%	15.1%	19.7%	-181
Aster Dm Healthcare LimitedASTERDMASTERDM	₹37,521 Cr	₹38,222 Cr	₹6,508 Cr	₹1,372 Cr	19.4%	₹471 Cr	9.2%	11.9%	9.7%	-112
Krishna Institute Of Medical Sciences LimitedKIMSKIMS	₹29,053 Cr	₹32,297 Cr	₹4,596 Cr	₹889 Cr	20.5%	₹212 Cr	6.2%	9.5%	11%	-50
Dr. Agarwal's Health Care LimitedAGARWALEYEAGARWALEYE	₹17,567 Cr	₹17,724 Cr	₹2,363 Cr	₹652 Cr	27.4%	₹173 Cr	8.1%	10.1%	6.8%	-76
Rainbow Childrens Medicare LimitedRAINBOWRAINBOW	₹13,014 Cr	₹13,014 Cr	₹1,923 Cr	₹596 Cr	32%	₹292 Cr	16.5%	18.2%	17.9%	-73
Park Medi World LimitedPARKHOSPSPARKHOSPS	₹11,151 Cr	₹11,379 Cr	₹1,679 Cr	₹444 Cr	26.5%	₹258 Cr	16.3%	21.4%	16.7%	-2
Yatharth Hospital & Trauma Care Services LimitedYATHARTHYATHARTH	₹10,052 Cr	₹10,305 Cr	₹1,486 Cr	₹348 Cr	24.2%	₹182 Cr	14.1%	12.3%	10%	-26
Paras Healthcare LimitedPARASHLTHPARASHLTH	₹8,724 Cr	—	—	—	—	—	—	—	—	—

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated figures · ₹ crore

No statements available

Annual statements haven't been ingested for this company.

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

No ratio history

Ratios derive from annual statements, which haven't been ingested yet.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2026
	63.95%
	11.5%
	20.58%
Government	0%
	3.97%
No. of shareholders	1,08,785

Promoter holding up 0 percentage points since Sep 2026.

Mr. Saurabh SoodDirector
Dr. Dharminder Kumar NagarDirector
Dr. Kapil GargDirector
Mr. Kabir ThakurDirector
Mr. Nakul AnandDirector
Mr. Upendra Prasad SinghDirector
Mrs. Usha RajeevDirector
Rahul KumarCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Schemes holding

6

across 2 fund houses

Held by these funds

4.91%

of the company's equity

All mutual funds

8.64%

shareholding pattern, Sept 2026

Portfolios as of

October 2026

no prior month

6 schemes · 2 fund houses

		Shares
Healthcare Opportunities Fund	SBI Mutual Fund	20.43 L	151.3	2.49%	1.888%	—
Multi Asset Allocation Fund	SBI Mutual Fund	17.28 L	128	0.62%	1.597%	—
Infrastructure Fund	SBI Mutual Fund	7.21 L	53.43	1.16%	0.667%	—
Balanced Hybrid Fund	SBI Mutual Fund	4.33 L	32.06	1.6%	0.4%	—
Dividend Yield Fund	SBI Mutual Fund	2.89 L	21.37	0.27%	0.267%	—
Health and Wellness Fund	Baroda BNP Paribas Mutual Fund	98,541	7.3	1.53%	0.091%	—

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

15

Offer and rights documents

5

Investor Presentation and earnings call

1

Nov 2026TranscriptAI SummaryPPTREC

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results5 Nov 2026 · 6 days agoresults

1

Board meeting to consider results5 Nov 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

15 announcementsExport CSV

6 Nov 2026, 7:21 pmCompany Update

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Analyst / Investor Meet PDF

5 Nov 2026, 8:11 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Directorate

Change in Directorate PDF

5 Nov 2026, 7:50 pmCompany Update

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release / Media Release PDF

5 Nov 2026, 7:26 pmResult

Result- Financial Results Sep 30, 2026

Financial Results PDF

5 Nov 2026, 7:15 pmBoard Meeting

Board Meeting Outcome for Board Approved Unaudited Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30, 2026

Outcome of Board Meeting PDF

3 Nov 2026, 7:50 pmCompany Update

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Analyst / Investor Meet PDF

2 Nov 2026, 7:42 pmBoard Meeting

Board Meeting Intimation for Considering And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026

Exchange filing PDF

30 Oct 2026, 5:12 pmCompany Update

Disclosure Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 As Amended ("SEBI SAST Regulations")

General PDF

Date	Category	Subject	Filing
6 Nov 2026, 7:21 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome	PDF
5 Nov 2026, 8:11 pm	Company Update Change in Directorate	Announcement under Regulation 30 (LODR)-Change in Directorate

Loading announcements…

Paras Healthcare Limited

Paras Healthcare Limited

About

Quick read

Pros

Cons

Peers

Financials

No statements available

Ratios

No ratio history

Shareholding

Quarterly record

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Offer and rights documents

Investor Presentation and earnings call

Events

Upcoming and recent1

Board meetings1

Announcements

Upcoming and recent1

Board meetings1

No ratio history

Announcements

Offer and rights documents

Investor Presentation and earnings call

Quarterly record

Board and management

Not in the F&O segment

No statements available

1

1

1

1